Introduction modulated by exposure to oxLDL (Hamilton et al., 1990; Fong et al., 1991; Malden et al., 1991) . Moreover, experiAtherosclerosis is responsible for more than half of all ments in cultured systems have suggested that oxLDL mortality in developed countries. The formation of the is able to stimulate its own uptake, presumably through atherosclerotic lesion is a complex process involving the induction of one or more scavenger receptors (Han et injured endothelium, monocytes/macrophages, smooth al., 1997) . The mechanisms by which oxLDL exerts these muscle cells, and a regulatory network of growth factors diverse effects have not been defined. and cytokines (reviewed in Ross, 1993) . The earliest
The nuclear hormone receptors comprise a family of macroscopically recognizable lesion of atherosclerosis transcription factors that regulates differentiation and is the fatty streak, an aggregation of cholesterol-laden cell and tissue homeostasis (Evans, 1988) . The tranmacrophages known as foam cells within the artery wall.
scriptional activity of these receptors is tightly controlled Although the sequence of morphological changes that by small lipophilic molecules that serve as ligands. The characterize the atherogenic process is well established production, availability, and metabolic stability of these (Buja et al., 1983) , the biochemical signals and regulatory molecules represents an important control point in the circuits that underlie the differentiation of foam cells processes regulated by their receptors. Peroxisome within atherosclerotic lesions remain poorly understood.
proliferator activated receptor ␥ (PPAR␥) is a nuclear There is a strong positive correlation between highreceptor that has been linked to adipocyte differentiaplasma low-density lipoprotein (LDL) levels and the detion and the control of cellular lipid uptake (Chawla et velopment of atherosclerosis. The pioneering work of Tontonoz et al., 1994b) . PPAR␥ forms a heteroBrown and Goldstein established that the principal pathdimeric DNA binding complex with the 9-cis retinoic way for macrophage uptake of LDL involves a group of acid receptor (RXR; Kliewer et al., 1992) and serves as a receptors distinct from the LDL receptor (Goldstein et transcriptional regulator of genes involved in adipocyte al ., 1979) . In order for LDL to be recognized by these lipid metabolism (Tontonoz et al., 1994a) . We have recently found that the PPAR␥:RXR heterodimer can regulate monocyte gene expression and differentiation and is expressed at high levels in the foam cells of athero- § To whom correspondence should be addressed.
These authors contributed equally to this work.
sclerotic lesions (Tontonoz et al., 1998 , this issue of Cell).
These observations suggest that endogenous PPAR␥ activators may function as important regulators of monocytic gene expression and may be present at high levels at sites of atherogenesis. The similarities between the biologic consequences of oxLDL exposure and the effects of ligand activation of PPAR␥:RXR heterodimers in myelomonocytic cell lines suggested the possibility that the oxLDL particle itself may be a source of endogenous PPAR␥ ligand. We demonstrate here that oxLDL can regulate PPAR␥-dependent transcription following scavenger receptor-mediated cellular uptake. Moreover, we identify two of the major oxidized lipid components of oxLDL, 9-HODE and 13-HODE, as endogenous activators and ligands of PPAR␥. These results establish a novel molecular mechanism linking oxLDL to the transcriptional control of macrophage gene expression and suggest an unexpected role for PPAR␥ in the pathogenesis of atherosclerosis.
Results

OxLDL and PPAR␥ Ligands Trigger Monocyte Maturation
Human peripheral blood monocyte cultures and the hu- 150 g protein/ml LDL or oxLDL, either alone or in comin the absence or presence of 100 nM LG268 and 100 g protein/ bination with 100 nM of the RXR-selective ligand LG268 ml lipoproteins, THP-1 cells were washed, replated, and incubated (Boehm et al., 1995) . Induction of the differentiationwith DiI-labeled oxLDL. Cell-associated fluorescence was quantilinked surface antigen CD14 was analyzed by flow cytated by flow cytometry. The data are presented as increase in tometry. As shown in Figure 1A , both 15d-PGJ2 and specific oxLDL association. In these experiments, the fluorescence oxLDL induced expression of CD14 on human monoof the oxLDL ϩ LG268-treated culture represents a 5-fold increase over background. The experiments were repeated three times with cytes (approximately 3-fold), while LDL did not. Surprissimilar results. ingly, the activity of both 15d-PGJ2 and oxLDL was enhanced by addition of LG268. The combination of oxLDL and LG268 also led to an induction of CD14 uptake observed in THP-1 cells. The two scavenger reexpression in THP-1 cells ( Figure 1B ). These cells were ceptors most clearly linked to oxLDL uptake in vivo are generally less responsive than human peripheral blood SR-A (Matsumoto et al., 1990; Suzuki et al., 1997) and monocytes, and combined treatment of PPAR␥-activa-CD36 (Endemann et al., 1993; Nozaki et al., 1995; Huh tors or oxLDL and LG268 was employed to induce maxiet al., 1996) . We performed Northern analysis of total mal response. cellular RNA from THP-1 cells to determine whether We next explored the ability of oxLDL and RXR ligands expression of mRNA encoding either CD36 or SR-A type to regulate macrophage uptake of oxLDL in vitro. THP-1 I/II was regulated by exposure to oxLDL. As shown in cells were preincubated for 4 days with 100 g/ml native Figure 2A , while unstimulated THP-1 cells expressed or oxidized LDL in the presence or absence of LG268.
little detectable mRNA for either SR-A or CD36, stimulaThe cells were then washed, replated, and incubated tion with the combination of oxLDL and LG268 resulted for 4 hr in the presence of 20 g/ml DiI-labeled oxLDL in a marked up-regulation of SR-A type I mRNA and and the cell-associated fluorescence quantitated by multiple splicing variants of CD36 mRNA. A smaller inflow cytometry. As shown in Figure 1C , both LG268 duction of CD36 and SR-A expression was observed and oxLDL induced a similar small increase in label when cells were treated with oxLDL alone (data not association. The combination of the two, however, reshown). sulted in a synergistic increase, approximately 4-fold
The expression of CD36 on the surface of oxLDLgreater than that seen with either treatment alone. As treated human peripheral blood monocytes and THP-1 expected, LDL failed to stimulate uptake of oxLDL, and cells was examined by flow cytometry using a monothe combination of LDL and LG268 was not different clonal antibody to CD36. A shown in Figure 2B , the from LG268 alone.
amount of immunoreactive CD36 on human monocytes was significantly increased when cells were treated with OxLDL Induces Expression of Scavenger the combination of 50 g/ml oxLDL and LG268 or 15d-Receptors SR-A and SR-B (CD36) PGJ2 and LG268. Similarly, in THP-1 cells, a strong We next endeavored to determine which cell surface receptor(s) were associated with the inducible oxLDL induction of surface CD36 expression was observed following treatment with the combination of oxLDL and
LG268 would potentiate the transcriptional activity induced by oxLDL. Figure 3B shows that the addition of LG268, as well as with the combination of LG268 and a 100 nM LG268 to increasing doses of oxLDL resulted PPAR␥-specific ligand (troglitazone [TRO] or 15d-PGJ2; in a synergistic activation of the reporter gene. The dif- Figure 2C ). Consistent with the Northern analysis (Figure ference between control and simultaneous treatment 2A), an induction of surface SR-A expression was dewith 50 g protein/ml oxLDL and LG268 is more than tected following treatment with oxLDL but not with 30-fold. While these data indicated that oxLDL can influ-PPAR␥-specific ligands (Tontonoz et al., 1998, and data ence the transcriptional activity of the PPAR␥:RXR hetnot shown).
erodimer, it was not clear whether this effect reflected ligand-dependent or ligand-independent activation.
The Oxidized LDL Particle Stimulates
If a ligand is involved in the activation of the receptor, PPAR␥-Dependent Transcription then the ligand-binding domain (LBD) of PPAR␥ should The ability of both PPAR␥ ligands and oxLDL to synerbe sufficient for transactivation. We therefore employed gize with LG268 in the induction of CD14 and CD36 a chimeric receptor/reporter system in which the ligandexpression suggested that some of the biologic effects binding domain of mPPAR␥ is fused to the DNA-binding of oxLDL might be mediated by transcriptional events domain of the yeast transcription factor Gal4. The chiinvolving the PPAR␥:RXR heterodimer. To explore this meric receptor is able to bind to the Gal4 DNA binding possibility, we assayed the ability of native and oxidized motif but activates transcription only in response to lilipoproteins to modulate the activity of PPAR␥ in trangands bound to the LBD of PPAR␥ (Forman et al., 1995) . sient transfection systems. A PPARE (peroxisome prolifThis assay system is independent of endogenous PPAR erator activated receptor response element)-containing and RXR and is a sensitive and specific reporter of ligand reporter gene was transfected into CV-1 cells along with binding the PPAR␥ LBD. Figure 3C demonstrates that CMX-hPPAR␥ and CMX-hRXR␣ expression vectors in the transcriptional activity induced by exposure to oxLDL the presence of either native or oxidized LDL. Native depends on the presence of both the GAL4 response LDL had no influence on reporter activity, even at high element (UAS) and the PPAR␥ LBD. This effect is clearly concentrations (50-150 g/ml; Figure 3A and data not dose-dependent, resulting in a greater than 10-fold inshown). Surprisingly, however, oxLDL stimulated recrease in reporter activity at doses of 150 protein g/ porter activity in a dose-dependent manner at concenml of oxLDL. Reporter activity was further stimulated trations as low as 10 g/ml, indicating that oxLDL was by addition of the RXR-specific ligand LG268 in the activating PPAR␥-mediated transcription.
presence of cotransfected RXR-LBD (data not shown). The activity of the PPAR␥:RXR heterodimer is maximal
We also explored whether there was any correlation when both receptors are bound by their respective libetween the length of time the LDL particle was subjected to oxidative conditions and the ability to induce gands (Kliewer et al., 1992) . We therefore tested whether transcription of the reporter gene. Figure 3D compares et al., 1989) induced a 3-fold activation. Remarkably, two oxidized metabolites of linoleic acid, 9-hydroxyocthe activity of LDL oxidized for various lengths of time (from 0.5 to 24 hr) in the transient transfection assay.
tadecadienoic acid (9-HODE) and 13-hydroxyoctadecaFrom this experiment, it is clear that the longer the oxidadienoic acid (13-HODE) were potent activators (Figure tion period, the greater the transcriptional response.
4A). At a concentration of 20 g/ml, these compounds Thus, the differential ability of LDL and oxLDL to activate induced 12-and 7.5-fold inductions of the reporter gene, PPAR␥ is directly related to the oxidation state of the respectively. 9-HODE cholesteryl ester was inactive, inparticle.
dicating that cleavage of the ester bond is critical for transport and/or receptor activation. The end product Oxidized Linoleic Acid Activates PPAR␥ of oxidized fatty acid metabolism, 4-OH nonenal, was The oxidation of LDL is a complex process involving also inactive. both the protein and the lipid moieties of the particle
The oxidation of linoleic acid in vivo is mediated by 15-(reviewed in Steinberg, 1997) . Each of the lipid compolipoxygenase and free oxygen radicals, resulting in hynents can undergo oxidation, including sterols, phosdroperoxy, hydroxy, and oxo metabolites (Steinbrecher pholipids, cholesterol esters, and triglycerides. Since et al., 1984; Kuhn et al., 1994; Folcik et al., 1995) . Interestcertain fatty acid derivatives such as prostaglandin J2 ingly, the activity of these structural and metabolic isohave been shown to serve as ligands for PPAR␥ (Forman mers in the transfection assay were remarkably similar. et al., Kliewer et al., 1995 Kliewer et al., , 1997 , we hypothesized
The (S) stereoisoform of both 9-and 13-HODE were that oxidation of one or more of the lipid components slightly more potent than the (R) stereoisoforms, and of oxLDL might result in the formation of an effective the oxo metabolites were slightly more potent than the PPAR␥ activator. To test this hypothesis, we conducted hydroxy ones ( Figure 4B ). To determine the concentraa screen of oxidized sterols and fatty acids that are tion required for PPAR␥ activation, a dose response known to be present in the oxLDL particle. Again, we curve was constructed for 9(S)-HODE and 13(S)-HODE. utilized a transient transfection assay that combines a As shown in Figure 4C , 9(S)-HODE was more potent chimeric Gal4-PPAR␥ LBD receptor and a UAS-conthan 13(S)-HODE, and both compounds exhibited dosetaining reporter gene. Following transfection, CV-1 cells dependent activation of the reporter in the range of 2.5 were treated for 24 hr with 20-40 g/ml of the indicated M-60 M. compounds ( Figure 4A ). Neither cholesterol nor any of its oxidized metabolites we tested induced transcriptional 9-HODE and 13-HODE Induce Monocyte activity in this assay. Among the free fatty acids tested, Maturation and Induce Scavenger oleic acid, erucic acid, and linoleic acid were inactive;
Receptor Expression linolenic acid and arachidonic acid showed minimal ac-
The above data indicated that linoleic acid metabolites tivity (1.5-to 3-fold induction of the reporter gene). The 15-OH metabolite of arachidonic acid (15-HETE; Simon oxidized at the 9 or 13 positions can serve as novel PPAR␥ activators. We then asked whether these compossibility, we established a ligand displacement assay using a baculovirus-expressed full-length mouse PPAR␥ pounds alone could recapitulate some of the biologic activities of the intact oxLDL particle. The ability of 9-HODE 1-GST fusion protein immobilized on glutathione-Sephand 13-HODE to induce differentiation-linked surface arose beads and [ and oxidized fatty acids to compete for [ 3 H]-BRL49653 ml 9-HODE increased CD14 expression levels on both binding was determined using this assay. As expected human monocytes and THP-1 cells ( Figures 5A and 5B) . from previous work, BRL49653 and 15d-PGJ2 (10 M) Moreover, this activity was potentiated by simultaneous were effective competitors for [ 3 H]-BRL49653 binding treatment with the RXR-selective retinoid LG268. A simi-( Figure 6A ). Interestingly, the oxidized metabolites of lar induction of CD36 expression was observed in THP-1 linoleic acid 9-HODE, 9-oxoODE, 13-HODE, and 13-cells ( Figure 5C ). Again, both 9-and 13-HODE alone oxoODE (100 M) were also effective competitors. Other induced a significant increase in CD36 expression (note oxidized components of the oxLDL particle, such as the shift of the fluorescence histogram), and simultane-7-keto cholesterol, failed to compete ( Figure 6A and ous treatment with LG268 had a synergistic effect. Condata not shown). Dose response competition curves sistent with the transactivation studies (Figure 4 ), 9-HODE ( Figure 6B ) were constructed to compare the in vitro was more potent than 13-HODE. In similar experiments, binding affinity of known synthetic and natural PPAR␥ no change in surface SR-A I/II expression was observed ligands with 9-and 13-HODE. The relative affinity of (data not shown). Taken together, these results strongly these compounds for binding to PPAR␥ correlates suggest that oxLDL can regulate macrophage gene exwell with their potency in transient transfection assays: pression by providing the cell with endogenous activa-BRL49653 Ͼ 15d-PGJ2 Ͼ 9-HODE Ͼ 13-HODE. While tors of PPAR␥.
we have not formally determined binding constants, these data suggest that the Kd for 9-and 13-HODE binding is likely to be in the 10-20 M range, approximately 9-HODE and 13-HODE Are Ligands of PPAR␥ an order of magnitude higher than 15d-PGJ2. This is in Next, we investigated whether oxidized linoleic acid metabolites could bind directly to PPAR␥. To explore this good agreement with the effective concentration of ure 4). The oxo metabolites of linoleic acid showed somewhat higher affinity binding to PPAR␥ (13-oxoODE Ͼ 9-oxoODE Ͼ 9-HODE Ͼ 13-HODE), consistent with their into the cell, (3) selective lipid uptake from membranepotency as transcriptional activators (data not shown).
bound oxLDL particles, and (4) intracellular release of ligand following endocytosis of the particle. To determine whether free ligand was diffusing from Activation of PPAR␥ by OxLDL Involves Scavenger Receptor-Mediated Cellular Uptake the oxLDL particle over time, we passed the oxLDL preparation through a filter with a molecular weight cutThe above observations strongly suggest that the ability of oxLDL to activate PPAR␥-dependent transcription off of 10,000 and examined the ability this material to activate PPAR␥-dependent transcription. No PPAR␥ acstems from its ability to provide the cell with oxidized linoleic acid ligands of PPAR␥. Since this represents a tivation was observed with the Ͻ10 kDa fraction while the Ͼ10 kDa fraction yielded an activation profile identinovel pathway for activation of a nuclear receptor, we endeavored to characterize in detail the molecular mechcal to that of unfiltered oxLDL (data not shown). This finding indicates that the PPAR␥ ligand is confined to anisms involved in the delivery of PPAR␥ ligand from the oxLDL particle to the nucleus. Theoretically, four the oxLDL particle and is not passively released into aqueous solution. different mechanisms of PPAR␥ activation are possible:
(1) passive diffusion of ligand from the particle into the Early in the course of this work, it was noted that oxLDL could activate PPAR-dependent transcription in cell, (2) facilitated transport of extracellular free ligand Figure 3 and treated with 100 g protein/ml LDL, oxLDL, or 20 g/ml 9-HODE. Normalized reporter activity was determined, and the means of three independent determinations Ϯ SD are shown. (B) Association of DiI-LDL and DiI-oxLDL to CV-1 and HeLa cells. Cells were incubated in the presence of fluorescent-labeled lipoprotein and cell-associated fluorescence was determined by flow cytometry. Mean fluorescence intensities are presented. (C) Cellular uptake of DiI-labeled LDL (i and ii) and oxLDL (iii and iv) by HeLa and CV-1 cells. Cells were incubated in the presence of 50 g/ ml DiI-labeled LDL or oxLDL and internalized label was visualized by fluorescence microscopy. (D) Ectopic expression of the scavenger receptor CD36 facilitates activation of PPAR␥-dependent transcription by oxLDL. CV-1 cells were transfected with the Gal-mPPAR␥-LBD based reporter system in the presence or absence of an expression vector for mCD36 and 50 g protein/ml oxLDL. Normalized luciferase activity and fold induction were determined, and the means of three independent determinations Ϯ SD are shown. Figure 7A ). One possible with CV-1 and HeLa cells. Figures 7B and 7C demonstrate that while LDL associates with both cell lines, explanation for this phenomenon was that CV-1 cells but not HeLa cells expressed a selective transporter oxLDL associates only with CV-1 cells. This association is saturable ( Figure 7B ) and can be competed with exthat facilitated uptake of free PPAR␥ ligand. This possibility was excluded by the observation that free 9-HODE cess unlabeled oxLDL (data not shown), indicating that it is receptor-mediated. Several conclusions can be drawn and thiazolidinedione ligands can activate PPAR␥ in both CV-1 and HeLa cells ( Figure 7A and data not shown). from these studies. First, the differential ability of native LDL and oxLDL to activate PPAR␥ does not reflect differAn alternative possibility was that CV-1 and HeLa cells differed in their ability to bind and/or internalize the ential association of these particles with CV-1 cells. Both associate, but only oxLDL activates. Second, cell assooxLDL particle itself. As a first step in addressing this possibility, we compared cell association (a combinaciation of the oxLDL particle is apparently required for activation of PPAR␥. Last, the kinetics of oxLDL binding tion of binding and uptake) of DiI-LDL and DiI-oxLDL to CV-1 cells is consistent with a scavenger receptorDiscussion mediated process (Endemann et al., 1993) and correlates well with the concentration of oxLDL (10-50 g/ Oxidized LDL has been hypothesized to play a causative ml) needed for activation of PPAR␥-dependent tranrole in atherosclerotic plaque formation (reviewed in scription ( Figures 3A and 3C) . Steinberg, 1997) . Oxidative modification of cholesterol, Next, we examined whether the mechanism of PPAR␥ fatty acid, and protein components of LDL results in the activation by oxLDL involves internalization of the entire formation of a lipoprotein particle with distinct biologic particle or the selective uptake of lipid from a receptoractivities. We have shown here that oxLDL activates bound particle. For example, cellular uptake of choles-PPAR␥-dependent transcription through a novel signalterol from LDL involves receptor-mediated endocytosis ing mechanism involving scavenger receptor-mediated of the particle (Goldstein and Brown, 1977) , while chocellular uptake. A screen of lipid components of the lesterol uptake from HDL particles by the HDL receptor oxLDL particle identified two oxidized metabolites of SR-BI occurs by selective lipid uptake (Acton et al., linoleic acid (9-HODE and 13-HODE) that were able to 1996). Krieger and associates have shown that these bind and activate PPAR␥. These findings suggest that two uptake mechanisms result in dramatically different 9-and 13-HODE may function as pathologic endogecellular distributions of the fluorescent lipid DiI (Acton nous ligands for PPAR␥ and play a direct role in the et al., 1996) . The fluorescence micrograph shown in Fig- regulation of macrophage gene expression during athure 7C compares the ability of HeLa and CV-1 cells to erogenesis. internalize fluorescent label (DiI) following exposure to Exposure of monocytes and macrophages to oxidized DiI-labeled LDL or oxLDL. Both lines readily internalized LDL has a range of biological consequences, including LDL (panels i and ii); however, only CV-1 cells internalenhanced monocyte maturation, increased adhesive ized oxLDL (compare panels iii and iv). Careful examinaproperties, expression of scavenger receptors, and protion reveals that internalization of DiI from either LDL duction of cytokines and growth factors (Lehr et al., or oxLDL resulted in a punctate fluorescence pattern 1993; Thomas et al., 1994; ; Lipton characteristic of receptor-mediated endocytosis to enet al., 1995; Han et al., 1997) . These diverse effects are dosomes and lysosomes ( Figure 7C , ii and iv insets).
CV-1 cells, but not in HeLa cells (
collectively thought to contribute to atherogenesis. As In order to obtain direct evidence for intracellular proone might expect, the influence of oxLDL on macrocessing of the apolipoprotein component of the particle, phage gene expression is complex and context-depen-CV-1 and HeLa cells were incubated in the presence of dent. Exposure of resting macrophages to oxLDL leads 125 I-labeled native and oxLDL. Intracellular degradation to increased expression of CD11b, CD18 (Lehr et al., was assayed by determining the radioactivity of the 1993), the scavenger receptors SR-A and CD36 (Han et acid-soluble material in the culture medium (Goldstein al., 1997; this work) , and cytokines such IL-1␣ and ILand Brown, 1977) . Both cell lines readily metabolized 1␤ (Thomas et al., 1994; Lipton et al., 1995) . At the same labeled native LDL (data not shown). However, in the time, oxLDL has been reported to suppress the INF␥-case of labeled oxLDL, the medium of CV-1 cells (3495 or LPS-induced expression of TNF␣, IP-10, and IL-1␤ cpm/plate) but not HeLa cells (1159 cpm/plate) con- (Fong et al., 1991;  Ohlsson et al., tained increased levels of acid-soluble radioactivity com-1996) . Interestingly, two groups have recently reported pared to the control (no cell) plates (1130 cpm/plate).
that PPAR␥ ligands can also function to suppress cytoThus, the oxLDL particle is internalized and processed kine production in activated macrophages (Jiang et al., by CV-1 cells. 1998; Ricote et al., 1998) . Thus, the effects of both oxLDL As a final test of this model, we investigated whether and PPAR␥ ligands on macrophage gene expression overexpression of the scavenger receptor CD36 could are dependent on the activation state of the cell. These facilitate activation of PPAR␥ by oxLDL. CD36 was origicontext-dependent effects may help to explain why nally identified as an oxLDL receptor by virtue of its oxLDL-exposed macrophages maintain a chronic rather ability to endow transfected cells with the capacity to than fulminant inflammatory reaction at sites of atherotake up oxLDL (Endemann et al., 1993) . Transient transsclerosis. fections of CV-1 cells were performed as above, and While the mechanisms that transduce signals from the ability of oxLDL to activate PPAR␥-dependent tranoxLDL to the nucleus are not well defined, previous scription was examined in the presence or absence of studies have suggested that isolated protein and lipid a cotransfected expression vector for murine CD36. As components can each recapitulate some of the effects shown in Figure 7D , cotransfection of the CD36 expresof the intact particle. For example, 9-HODE and 13-sion vector strongly enhanced the ability of oxLDL to HODE have been implicated in the induction of IL-1␤ (Ku function as a PPAR␥ activator in these cells. This experiet al., 1992) . Interestingly, the concentrations of these ment provides direct evidence that expression of the compounds needed to induce CD14 and CD36 in our cell surface oxLDL receptor CD36 is coupled to tranassays are identical to those reported by Ku et al. for scriptional activation by PPAR␥. Together with the data IL-1␤. Our identification of these compounds as activapresented above, this result strongly suggests that scavtors of PPAR␥ provides a novel mechanism to explain enger receptor-mediated internalization of the oxLDL at least some of the biologic effects of oxLDL. It is particle is required for activation of PPAR␥. Furthermore, important to note, however, that oxLDL also possesses since free 9-HODE cholesteryl ester (the predominant activities that are not shared with PPAR␥ ligands, such form of 9-HODE in the oxLDL particle) cannot activate as the ability to induce SR-A expression (Figure 2 ). These PPAR␥-dependent transcription, it is likely that intraceleffects may be mediated by surface receptor-linked siglular processing of the particle and cleavage of the ester bond are required for the liberation of PPAR␥ ligand.
naling pathways (Huang et al., 1991) . , 1990) . Given the tremendous amount of oxidized LDL accumulated by foam cells in vivo, the intracellular concentration of 9-and 13-HODE within foam cells in vivo is very likely to exceed the concentration required for activation of PPAR␥. Cell surface receptor-mediated endocytosis of a lipoprotein particle represents a previously unrecognized mechanism of ligand delivery to a nuclear receptor. Unlike other nuclear receptor activators such as steroid hormones, which gain easy access to the nucleus because of their lipid solubility, oxLDL is apparently able to activate PPAR␥-dependent transcription only in cells that can bind and internalize the oxLDL particle via scavenger receptors. In this novel pathway, signaling through a surface receptor is directly coupled to signaling through components of oxLDL, 9-, and 13-HODE, are present in the form of cholesteryl esters. Since free 9-HODE PPAR␥ was originally identified as an orphan nuclear cholesteryl ester was inactive in transient transfection receptor and an adipocyte transcription factor (Kliewer experiments, we speculate that both scavenger recepet al., 1992; Tontonoz et al., 1994a) . It has been rescued tor-mediated uptake and lysosomal hydrolysis are likely from the orphanage by the identification of naturally to be indispensable for the generation of ligand from occurring (15d-PGJ2) and synthetic (thiazolidinedione) the oxLDL particle. An intriguing possibility is that liligands (Forman et al., 1995; Kliewer et al., 1995; Leh- gands for other nuclear receptors may also be generated mann et al. , 1995) . Recently, it has been demonstrated from lipoprotein particles by similar mechanisms. that certain members of the PPAR family (␣ and ␦) can
The lipoprotein metabolism of macrophages is fundarecognize a broad array of polyunsaturated fatty acids, mentally different from that of other cells. Macrophages including linoleic and arachidonic acid (Forman et al., internalize modified LDL through scavenger receptors, 1997; Kliewer et al., 1997) . In the case of PPAR␥, while which unlike LDL receptors, are not down-regulated by some labs have found polyunsaturated fatty acids such high intracellular cholesterol levels (for a review, see as linoleic acid to be activators at high concentrations Brown and Goldstein, 1983) . On the contrary, exposure (Kliewer et al., 1997) , we have reported that these fatty to higher oxLDL levels results in increased receptor exacids are relatively poor activators of PPAR␥ compared pression. As a result, macrophages incubated continuto the other PPARs (Forman et al., 1997) . In the present ously with oxLDL are converted into foam cells. This work, we have shown that oxidative modification of linophenomenon implies the existence of a mechanism leic acid results in the formation of more effective PPAR␥ whereby the scavenger receptor substrate (i.e., oxLDL) activators. While this finding has important implications initiates and promotes its own uptake by increasing the for PPAR␥ signaling in macrophages, it remains to be level of receptor expression. Collectively, the data predetermined whether activation by oxidized fatty acids sented in this work and in the accompanying paper plays a significant role in PPAR␥-mediated processes (Tontonoz et al., 1998) implicate the PPAR␥:RXR heteroin other tissues. Interestingly, oxLDL, like other PPAR␥ dimer in a signaling pathway that couples cellular uptake activators, can promote the differentiation of cultured of oxLDL with transcriptional activation of the scavenger adipocyte cell lines (our unpublished data).
receptor CD36 by PPAR␥ (Figure 8 ). Oxidative modificaThere is considerable evidence to support a role for tion of the LDL particle endows it with the ability to bind oxidized fatty acids as important signaling molecules in scavenger receptors and at the same time converts a the context of the athersclerotic lesion. Oxidized lipids, component of the particle, linoleic acid, into an effective including oxidized fatty acids, were detected in atheroactivator of PPAR␥ (9-HODE, 13-HODE). Thus, as a consclerotic lesions in the early 1950s (Glavind et al., 1952;  sequence of oxLDL internalization by receptor-mediYla- Herttuala et al., 1989) . 9-and 13-HODE in particular ated endocytosis, an activating signal for PPAR␥ is forare present at high levels in advanced lesions. It has warded to the nucleus. Transcriptional activation of been estimated that fibrous plaques contain 89 g oxi-PPAR␥ initiates a positive feedback loop that enhances dized fatty acid/g lipid (total sterol esters) and ulcerated the expression of the oxLDL receptor CD36. This attracplaques 335 g/g lipid (Harland et al., 1971) . It has also tive metacrine regulatory circuit suggests a novel mechbeen shown that the amount of 9-and 13-HODE in anism whereby oxLDL and its component lipids may human atherosclerotic lesions correlates directly with contribute to foam cell formation and the regulation of the severity of the lesion (Harland et al., 1971) . Since macrophage gene expression during atherogenesis. the work presented here has utilized oxLDL prepared in vitro, it is important to note that the lipid profile gener-
Experimental Procedures
ated by CuSO 4 -mediated oxidation is very similar to the profile of oxLDL in vivo (Lenz et al., 1990; Thomas and Materials Jackson, 1991 When necessary, a carrier plasmid (pGEM4) was added to ensure equal DNA amounts in each transfection. After 16 hr of transfection, (clone TUK4, DAKO), fluorescein isothiocyanate (FITC)-conjugated anti-human CD18 (clone MHM23, DAKO), and FITC-conjugated antimedium was changed and ligand or lipoproteins were added as indicated. Cells were harvested after 24 additional hr of growth, and mouse and anti-rabbit immunoglobulins (DAKO). Anti-human CD36 (clone 8A6) mouse monoclonal antibody was a kind gift of Dr. J.
luciferase activity was determined and normalized to the ␤-galactosidase activity. Each transfection was carried out in triplicate and Barnwell (NYU), and anti-human SR-AI/II was a kind gift of Dr. C. K. Glass (UCSD). Expression vectors for mouse and human repeated at least three times. PPAR␥ ( pCMX-mPPAR␥), hRXR␣ ( pCMX-RXR␣), Gal4-DBD fusion of mPPAR␥-LBD (pCMX-Gal-mPPAR␥-LBD), and hRXR␣-LBD ( pCMXLigand Binding Assays hRXR␣-LBD) reporter genes pMH-100-TK-luc or pPPAREx3-TK-luc Ligand binding assays were performed using a baculovirusand pCMX␤-gal were described previously (Forman et al., 1995) . expressed mPPAR␥1-GST fusion protein. SF9 cell pellets were lysed in 400 mM KCl, 20 mM TRIS (pH 8.0), 1 mM ETDA, 1 mM Cell Culture and RNA Analysis DTT, and 0.1% Triton X-100, and the fusion protein purified by THP-1, HeLa, and CV-1 cells were obtained from ATCC and cultured glutathione-Sepahrose affinity chromatography. The fusion proteinin RPMI 1640 medium (THP-1) or in DMEM (293, HeLa, CV-1) in the bound beads were used directly in a binding reaction with 100 nM presence of 10% FCS (Summit). THP-1 cells and human monocytes carrier (ethanol) were added as indicated. Following incubation for eral blood from healthy volunteers was collected in 10 mM sodium 2 hr at 4ЊC, the PPAR␥-Sepharose beads were isolated by centrifucitrate. Erythrocytes and neutrophils were removed by low-speed gation, washed with 10 vol of binding buffer, and the bound counts centrifugation in Vacutainer CPT cell preparation tubes (Becktondetermined by liquid scintillation counting. Each experiment was Dickinson) according to manufacturer's instructions. Cells were culrepeated three times with similar results. tured in RPMI 1640 with 10% autologous serum overnight, and nonadherent platelets and other cells were removed by washing. Acknowledgments Total RNA was isolated using TRIzol reagent (GIBCO-BRL). Northern analysis was performed as in Tontonoz et al. (1994a) . The cDNA
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